Mylan's Robert Coury - CEO Pay
Robert Coury - Mylan
Total Compensation: $8.54M
2007 Revenue: $2.17B
2006 Revenue: $1.61B
Change: 34%
Details: Mylan CEO and Vice Chairman Robert Coury brought down $10.3 million during fiscal 2007, which ran only nine months because the drugmaker changed its fiscal year. Coury earned salary of about $1.12 million, stock awards of $1.15 million, and about $2.1 million in incentive compensation. Mylan was the only company that primarily produces generics drugs to grace our top 17.
Mylan News:
Mylan CEO intent on new global biz
Mylan CEO makes $10M in 9 months
Comments
Post new comment
Paid Research Reports
- The Top 10 Biosimilar Players: Positioning, performance and SWOT analyses
- New Approaches to Pharma R&D: Evolving strategies to rejuvenate R&D efficiency
- Stakeholder Opinions: Vaccine antigen delivery technologies - Molecular systems to open new markets
- The Top 10 Contract Research Organizations
- Stakeholder Opinions: Vaccine administration technologies - Beyond needles
- Future Pharmaceutical Industry Trends: Long-term opportunities tempered by short-term challenges
Click here to get the FiercePharma email newsletter for FREE!
Be the first to comment